Cesano Alessandra, a director at Puma Biotechnology Inc. ($PBYI), sold shares on the open market twice in the last year, totaling about $132 thousand. Her most recent sale occurred on July 18, 2025. These $PBYI insider sales rank 9,167th among 11,678 individual insiders, compared to an average sale value of $8.6 million across about 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Zymeworks Inc. | $ZYME | Cesano Alessandra | Not found | A | Stock Option (Right to Buy) | 11500 | $0.00 | 11,500.0000 | 75,775,214 | 9999.99% | 0.02% |
| Jan. 12, 2026 | Zymeworks Inc. | $ZYME | Cesano Alessandra | Not found | A | Restricted Stock Unit | 7700 | $0.00 | 7,700.0000 | 75,775,214 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 3219 | $8.76 | 3,219.0000 | 744,442,538 | 9999.99% | 0.00% |
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 744,442,538 | 9999.99% | 0.00% |
| July 18, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Cesano Alessandra | Director | S | Common Stock | 27000 | $3.37 | 41,850.0000 | 49,100,433 | 39.22% | 0.05% |
| June 13, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Cesano Alessandra | Director | S | Common Stock | 12150 | $3.40 | 68,850.0000 | 49,100,433 | 15.00% | 0.02% |
| June 11, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Cesano Alessandra | Director | A | Common Stock | 27000 | $0.00 | 81,000.0000 | 49,100,433 | 50.00% | 0.05% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 3073 | $9.18 | 3,073.0000 | 0 | 9999.99% | 0.00% |
| Dec. 10, 2024 | Zymeworks Inc. | $ZYME | Cesano Alessandra | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| June 18, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Cesano Alessandra | Director | A | Common Stock | 27000 | $0.00 | 54,000.0000 | 47,550,852 | 100.00% | 0.06% |
| March 25, 2024 | ESSA Pharma Inc. | $EPIX | Cesano Alessandra | Chief Medical Officer | A | Options | 200000 | $0.00 | 200,000.0000 | 44,129,491 | 9999.99% | 0.45% |
| Feb. 8, 2024 | Zymeworks Inc. | $ZYME | Cesano Alessandra | Not found | A | Stock Option (Right to Buy) | 74000 | $0.00 | 74,000.0000 | 68,863,010 | 9999.99% | 0.11% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 21363 | $1.32 | 56,363.0000 | 0 | 61.04% | 0.00% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | Cesano Alessandra | Director | A | Common Stock | 27000 | $0.00 | 27,000.0000 | 44,929,998 | 9999.99% | 0.06% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 16350 | $1.67 | 51,350.0000 | 0 | 46.71% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Cesano Alessandra | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |